Europe PMC
open access
Diphenylpyraline Derivatives Are Allosteric Agonists of the CB<sub>1</sub> Cannabinoid Receptor
Diphenylpyraline analogs JKH1 and JKH10 are monoamine transporter inhibitors and promote relaxation in mouse mesenteric arteries. Here, we evaluated JKH1 and JKH for their interaction with CB1 cannabinoid receptor signaling. In N18TG2 mouse neuroblastoma cells that endogenously express CB
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Diphenylpyraline Derivatives Are Allosteric Agonists of the CB1 Cannabinoid Receptor#1469412
- PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP#1309974
- Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use#1376211
- Genomic and structural analysis of the endocannabinoid system in Moroccans: A novel CNR1 variant (V392A) impairs CB1 receptor stability#146551
- Exploring Synthesized CBD Derivatives: Implications of Therapeutic Strategies for Neuroinflammation#219785
Record · ID 1500391
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive